ArticleRMD open2022

Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients.

José Luis Martín-Varillas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.